References
- Urgent Field Safety Notice. Clin Chem fully automated. FSN-RPD-2015-011, Version 4, June 2015.
- Schröder H, Campbell DE. Absorption, metabolism, and excretion of salicylazosulfapyridine in man. Clin Pharmacol Ther 1972;13:539–51.
- Azadkhan AK, Truelove SC, Aronson JK. The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. Br J Clin Pharmacol 1982;13:523–8.
- CLSI. Interference Testing in Clinical Chemistry; Approved Guideline - Second Edition. CLSI document EP07-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2005.
- Westgard QC. Desirable Biological Variation Database Specifications. Available at: http://www.Westgard.com/biodatabase1.htm. Accessed: September 2015.
- Ucar F, Erden G, Ozdemir S, Ozcan N, Bulut E, Ozturk A. First data on the biological variation and quality specifications for plasma ammonia concentrations in healthy subjects. Clin Chem Lab Med. 2015; doi: 10.1515/cclm-2015-0591.